[Update on treatment of multiple myeloma: including myeloma kidney and molecular targeting drugs]

MeSH terms

• Boronic Acids / adverse effects
• Boronic Acids / pharmacology
• Boronic Acids / therapeutic use
• Bortezomib
• Drug Design*
• Humans
• Immunologic Factors / adverse effects
• Immunologic Factors / pharmacology
• Immunologic Factors / therapeutic use
• Kidney Neoplasms / drug therapy*
• Lenalidomide
• Molecular Targeted Therapy*
• Multiple Myeloma / drug therapy*
• Oligopeptides / adverse effects
• Oligopeptides / pharmacology
• Oligopeptides / therapeutic use
• Plasmacytoma / drug therapy*
• Pyrazines / adverse effects
• Pyrazines / pharmacology
• Pyrazines / therapeutic use
• Thalidomide / adverse effects
• Thalidomide / analogs & derivatives
• Thalidomide / pharmacology
• Thalidomide / therapeutic use